Efficacy and Safety of an NRTI-Sparing Dual Regimen of Raltegravir and Ritonavir-Boosted Protease Inhibitor in a Triple Antiretroviral Class-Experienced Population-Reference-Cited by-同舟云学术

Efficacy and Safety of an NRTI-Sparing Dual Regimen of Raltegravir and Ritonavir-Boosted Protease Inhibitor in a Triple Antiretroviral Class-Experienced Population

Published:2009-10 Issue:5 Volume:10 Page:337-340
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Allavena C.,Mounoury O.,Rodallec A.,Reliquet V.,Billaud E.,Raffi F.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1310/hct1005-337

Reference9 articles.

1. Antiretroviral Treatment of Adult HIV Infection

2. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults

3. Is Dual Therapy With Raltegravir and Protease Inhibitors a Feasible Option in Rescue Strategy in HIV-1 Infection?

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics of Lipid Profile in Antiretroviral-Naïve HIV-Infected Patients, Treated with TAF-Based Regimens: A Multicenter Observational Study;Biomedicines;2022-12-07

2. Efficacy of raltegravir-containing regimens in antiretroviral-naïve and -experienced individuals in routine clinical practice;International Journal of STD & AIDS;2016-07-11

3. Antiretroviral Treatment in Older Patients;Managing the Older Adult Patient with HIV;2016

4. HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors;Annals of Internal Medicine;2015-12-15

5. Efficacy and Safety of Darunavir/Ritonavir Plus Etravirine Dual Regimen in Antiretroviral Therapy–Experienced Patients: A Multicenter Clinical Experience;HIV Clinical Trials;2014-08